Doctor Fernando Scudiero
Bolognini Hospital, Seriate (Italy)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Dual antiplatelet therapy with 3rd generation P2Y12 inhibitors in STEMI patients: impact of Body Mass Index on high on-treatment platelet reactivity
Event: ESC Congress 2021 - The Digital Experience
Topic: Antiplatelet Drugs
Session: Pharmacology and pharmacotherapy e-posters
Hyperthyroidism in Takotsubo syndrome: prevalence, clinical features and long-term outcomes.
Event: ESC Congress 2020
Topic: Takotsubo Cardiomyopathy
Session: Evolving Concepts in MINOCA
Platelet reactivity in Hepatitis C virus infected patients on dual antiplatelet therapy for acute coronary syndrome
Event: ESC Congress 2019
Topic: Pharmacotherapy
Session: Acute Coronary Syndromes - Treatment antiplatelet
Percutaneous coronary intervention with 2nd generation drug eluting stent versus coronary artery bypass grafting in patients with unprotected left main disease: clinical outcome from a referral center
Event: ESC Congress 2019
Topic: Revascularisation
Session: Acute coronary syndrome - Procedural devices
Discriminatory ability of GRACE risk score to predict outcomes in patients with Takotsubo syndrome
Event: ESC Congress 2018
Topic: Takotsubo Cardiomyopathy
Session: Specials in cardiology: obstructive sleep apnea and Takotsubo syndrome
Relationship between uric acid and contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention: a meta-analysis and meta-regression
Event: ESC Congress 2017
Topic: CAD and comorbidities
Session: CAD and comorbidities
Discriminatory ability of CHA2DS2-VASc score to predict residual platelet reactivity and outcomes in patients with acute coronary syndrome
Event: ESC Congress 2017
Topic: Thrombosis and platelets
Session: Acute coronary syndromes: the full picture
ESC 365 is supported by
